Cresset Asset Management, LLC Bio N Tech Se Transaction History
Cresset Asset Management, LLC
- $25.6 Billion
- Q3 2024
A detailed history of Cresset Asset Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Cresset Asset Management, LLC holds 6,331 shares of BNTX stock, worth $744,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,331
Previous 11,827
46.47%
Holding current value
$744,588
Previous $950,000
20.95%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.22MShares$967 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$531 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$518 Million2.03% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$213 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...